XML 11 R4.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Statements of Operations (Unaudited) - USD ($)
 3 Months Ended
Jul. 31, 2024
Jul. 31, 2023
Operating expenses:    
Research and development $ 1,224,931 $ 565,632
Selling, general and administrative 850,736 765,023
Total operating expenses 2,075,667 1,330,655
Loss from operations (2,075,667) (1,330,655)
Other income (expense)    
Interest expense (22,526) (36,260)
Other income 46,504 60
Total other income (expense) 23,978 (36,200)
Net loss $ (2,051,689) $ (1,366,855)
Net loss per share, basic $ (2.64) $ (13.23)
Net loss per share, diluted $ (2.64) $ (13.23)
Weighted average common shares outstanding, basic 777,746 103,315
Weighted average common shares outstanding, diluted 777,746 103,315